A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Dose Titration Study of Nebivolol Monotherapy in Hispanic Patients With Stage 1 or Stage 2 Hypertension.

Trial Profile

A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Dose Titration Study of Nebivolol Monotherapy in Hispanic Patients With Stage 1 or Stage 2 Hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Dec 2010

At a glance

  • Drugs Nebivolol (Primary)
  • Indications Essential hypertension; Hypertension
  • Focus Therapeutic Use
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 23 Jul 2010 Results presented at the 25th Annual Scientific Meeting of the American Society of Hypertension in May 2010.
    • 05 May 2010 Results presented at the 2010 annual meeting of the American Society of Hypertension.
    • 01 May 2010 Primary endpoint 'Diastolic blood pressure' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top